All ICD10 Codes

DRG 016

Medical DRG

Autologous Bone Marrow Transplant with CC/MCC

TypeMedical

What is MS-DRG 016?

MS-DRG 016 is a Medical Medicare Severity Diagnosis Related Group with a Complication or Comorbidity (CC). Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.

Classification
Medical DRG
Diagnosis-driven grouping
MDC
Pre-MDC / Multi-MDC
Linked Codes
0 diagnosis
22 procedure

Linked ICD-10-PCS Procedure Mappings

  • 30233C0

    Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Peripheral Vein, Percutaneous Approach

    BillableSection 3
  • 30233G0

    Transfusion of Autologous Bone Marrow into Peripheral Vein, Percutaneous Approach

    BillableSection 3
  • 30233X0

    Transfusion of Autologous Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach

    BillableSection 3
  • 30233Y0

    Transfusion of Autologous Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach

    BillableSection 3
  • 30243C0

    Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Central Vein, Percutaneous Approach

    BillableSection 3
  • 30243G0

    Transfusion of Autologous Bone Marrow into Central Vein, Percutaneous Approach

    BillableSection 3
  • 30243X0

    Transfusion of Autologous Cord Blood Stem Cells into Central Vein, Percutaneous Approach

    BillableSection 3
  • 30243Y0

    Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach

    BillableSection 3
  • XW1337A

    Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10

    BillableSection X
  • XW133B8

    Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW133F8

    Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW133G8

    Transfusion of Atidarsagene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW133H9

    Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9

    BillableSection X
  • XW133J8

    Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW133SB

    Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11

    BillableSection X
  • XW1437A

    Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10

    BillableSection X
  • XW143B8

    Transfusion of Betibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW143F8

    Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW143G8

    Transfusion of Atidarsagene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW143H9

    Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9

    BillableSection X
  • XW143J8

    Transfusion of Exagamglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8

    BillableSection X
  • XW143SB

    Transfusion of Mozafancogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 11

    BillableSection X